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ABSTRACT. Using electrophoretic mobility shift assays  (EMSA), we have recently  shown that nuclear extracts of 14-day 
mouse fetal thymocytes contain abundant NF-KB transcription factor activity. To determine the functional  role  of 
NF-KB in early thymocyte development, we have exposed fetal thymus organ cultures to inhibitors of NF-KB 
activation, namely  the  antioxidants N-acetyl-L-cysteine and butylated  hydroxyanisole.  Both  compounds caused a 
dose-dependent arrest of thymocyte differentiation toward cup, but  not 76, T cells. This was associated with a 
profound decrease in nuclear  content of NF-KB and TCFl (a)  transcription  factor activity, as determined by EMSA. 
In contrast, NF-Y was affected less strongly, and cyclic AMP-response-element-binding protein levels remained 
essentially unchanged by antioxidants. To test the  idea that ap T cell development is correlated with NF-KB and 
TCFl (a)  activity, we  conducted  additional experiments in a submersion culture system in  which the generation of 
ap T  cells  can be manipulated. Standard submersion culture supports y6 but  not ap T cell development.  Under 
these conditions, EMSA showed that transcription  factor  activities  were  similar to those seen in the presence of 
antioxidants. Importantly, when the generation of ap T  cells in submersion culture was restored by elevating  oxygen 
concentrations, there was a  dramatic increase in TCFl(a) activity, and both NF-KB and NF-Y returned to 
control levels. Taken together, these results strongly suggest that NF-KB and TCFl(a), presumably in concert 
with other  transcription factors, play  an  important  role in the  development of ap T cells. journal of Immunology, 
1993, 151 : 4694. 
T ranscription factors are key regulators of differ- ential gene activity which in turn specifies cellular development and function (1). Using EMSA,3 we 
have  begun to study transcription factor activity during the 
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early development of T lymphocytes from hemopoietic pre- 
cursors in the fetal thymus (2). Thymocyte development 
was chosen as a system because it proceeds in phenotypi- 
cally well defined, contingent stages ( 3 ) .  In addition, organ 
culture of fetal thymi allows normal development to occur 
in vitro, greatly facilitating the experimental manipulation 
of this process (4). 
At day 10 of embryonic development, the mouse thymus 
is a cluster of epithelial cells which becomes colonized by 
hemopoietic precursor cells. By day 14, surface expression 
of yS TCR can be detected (on  about 3% of cells), but only 
truncated (1 .O kb) transcripts are found for the TCR p chain. 
Two days later, cells expressing both CD4 and CD8, so- 
called DP thymocytes, appear and express low levels of ap 
TCR in association with CD3. This population is subject to 
positive and negative selection by thymic stromal elements, 
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giving rise to mature SP  CD4 or CD8 cells  with high levels 
of aP TCR  (reviewed in reference 3).  Most  previous  studies 
on transcription  factors in developing  T  lymphocytes have 
focused on the regulation of aP TCR gene expression (5 ,  
6). For example, TCFl(a)/LEFl was identified as essential 
participant in TCR a-chain transcription, and is also in- 
volved in CD4 and Zck gene transcription (7-10). Another 
important factor controlling ap TCR (and several other 
genes in thymocytes) is the CREB (11-14). Little is known 
about transcriptional control of early  stages of thymocyte 
development  before aP TCR expression. We have recently 
observed that the 14-day fetal thymus contains abundant 
NF-KB activity, as determined by using EMSA (2). We 
reasoned that if NF-KB is important for early T cell de- 
velopment, then blocking NF-KB activity should have po- 
tent effects on thymocyte differentiation. Antioxidant  com- 
pounds  including NAC and BHA have recently been 
identified as inhibitors of nuclear NF-KB activity in a  num- 
ber of cell  lines (15-17). We therefore decided to add NAC 
and BHA to FTOC, and indeed  observed  decreased  levels 
of NF-KB and also TCFl(a) activity. Simultaneous phe- 
notypic  analysis  showed  a profound block in ap but not yS 
T  cell  development.  Similar  changes in transcription factor 
activity and phenotype of developing  thymocytes  were  ob- 
served in a submersion culture system. Importantly, ex- 
perimental rescue of ap T cell generation (by elevated oxy- 
gen concentration, reference 18) restored both NF-KB and 
TCFl(a) activity. 
Materials and Methods 
Culture  of fetal thymi 
Thymus lobes  were removed from approximately 100 
(C57BL/6 X SJL) F2 day 14 embryos and placed on Nu- 
cleopore  polycarbonate  filters  (0.8 pm pore size)  floating 
on 5 ml DMEM,  supplemented as described (19), in 60-mm 
Petri dishes (day 0). Four groups of two  filters each with 
25 lobes  were  set  up  containing 0 (Control), 20, 50, or 100 
mM NAC (Sigma  Chemical Co., St. Louis, MO). NAC was 
kept as a 1 M  stock  solution in DMEM brought to pH 7.4 
by NaOH. Before being placed on filters, lobes were in- 
cubated for 2  h in 5 ml medium containing the correspond- 
ing  concentrations of NAC.  After 24  to  48 h, lobes  were 
then transferred to fresh medium without NAC. For ex- 
periments with BHA, FTOC were treated for 24 h with 
concentrations of BHA ranging from 0.5 to 4.0 mM. In 
some experiments,  day 14 fetal thymi were  cultured sub- 
merged in medium.  These  cultures  were  supplemented  with 
10 U/ml recombinant  IL-2  where  indicated  (19, 20). Sub- 
mersion cultures  were maintained either in a standard at- 
mosphere of 5% C 0 2  in air (ambient O2 concentration of 
21%) or in a  mixture of 60% 02, 10% C02, and 20% N2 
as described recently (18). To facilitate  gas  exchange, these 
latter cultures were conducted in permeable Petri dishes 
(Petri-perm, Heraeus, Germany). 
Cellular  proliferation and IL-2 production 
Groups of FTOC  were treated for  24  h with NAC before 
being transferred to non-NAC-containing DMEM. After 9 
days,  cells  were harvested and duplicate  cultures  containing 
5,2.5,1.0,0.5, and 0.25 X 10' cells  set up in round-bottom 
microtiter plates. Cells  were  stimulated  with 1 ng/ml PMA 
(Sigma) and 500 ng/ml Ionomycin  (Calbiochem Corp., La 
Jolla, CA)  as described previously (19). After 24 h, 100 pl  
of SN was  collected, replaced with 100 pl  of fresh  medium, 
and after 48 h  cells were pulsed for 5 h with 1 pCi t3H]- 
thymidine before harvesting and counting. The SN were 
assayed for  IL-2 content using CTLL cells as previously 
described (19)  along with r-IL-2 (Cetus) as IL-2 control. 
Immunofluorescence  staining  and flow cytornetry 
At  the  times indicated, between 2 and 8  lobes from each 
group  were  pooled, and cell suspensions prepared by minc- 
ing with cataract knives, and then gently passing them 
through a 26-gauge hypodermic needle. Viable cells  were 
counted in a hemocytometer. Cells  were washed in medium 
and 3 X lo4 to 2 X 10' cells incubated for 30 min  at 4°C 
with saturating concentrations of FITC-labeled anti-CD8 
and PE-conjugated anti-CD4  mAb (Becton-Dickinson, 
Mountain View, CA) diluted in 50 p1 DMEM or in medium 
alone (unstained samples). For three-color analysis, cells 
were  stained with biotinylated anti-CD3  mAb 500A2 (Fig. 
4A), anti-TCR P-chain  H57 mAb (Fig.  4B), anti"$ TCR 
mAb GL3 (Fig. 3C), or anti-CD25, IL-2Ra chain, mAb 
PC61 (Fig. 3) followed by streptavidin-cychrome (PharM- 
ingen, San Diego, CA), and subsequently incubated with 
anti-CD4-PE and anti-CD8-FITC  mAb.  Controls were 
stained with all reagents except the biotinylated mAb. After 
washing,  cells  were analyzed unfixed (except for those at 
21 days which were fixed in 1% paraformaldehyde in PBS) 
on a FACScan flow cytometer (Becton Dickinson) and 
compensations  set using singly and doubly labeled samples 
of normal adult thymocytes. Viable cells  were identified by 
a  combination of forward and side scatter signals, and 5 to 
20 X lo3 cells were acquired per sample. 
Oligonucleotides and  electrophoretic mobility shift 
assay 
Synthetic  oligonucleotides  were  end-labeled with [ Y - ~ ~ P ] -  
ATP using T4 polynucleotide kinase (22). Sequences of 
double-stranded oligonucleotides used in this study are 
shown in Table I. Nuclear extracts  were prepared from fresh 
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Table I 
Oligonucleotides  with  binding sites for  transcription factors 














rnKB (mutated site)b 
CRE/CREB TCRa 
CD4 = 2/TCFl(a) 
mCD4 = 2 (mutated site) 
Y-box/NF-Y MHCII(Ea) 
Collagenase 
Ta2nCF-l (a) TCRa 
CD4 
Known binding sites of transcription factors  are underlined. 
Mutated nucleotides are shown in bold. 
fetal, newborn, or adult (C57BW6 X SJL) F2  mouse thy- 
mocytes  using the techniques described by Dignam et al. 
(23) and Schreiber et al. (24). Buffers for extraction of 
nuclear proteins contained the protease inhibitors PMSF 
(0.5 mM) and 5 pg/ml each of leupeptin, aprotinin, pep- 
statin,  chymostatin, and antipain. Proteins  were quantitated 
according to Bradford (25). Binding reactions were con- 
ducted by incubating the end-labeled DNA (20,000  cpm) 
with 1 or 2 pg of nuclear proteins and 2 p,g of poly(d1-dC) 
in a buffer containing 10 mM HEPES, pH 7.9,60 mM KCl, 
4% Ficoll, 1 mM EDTA. After 30 min at room temperature, 
the reaction mixtures were loaded onto a 4% polyacryl- 
amide  gel  in 0.25 X TBE buffer (89 mM Tris, 89 mM  boric 
acid, 2  mM EDTA) and electrophoresed at 10 V/cm for 1.5 
h at room temperature. For competition experiments, a 100- 
to 200-fold molar excess of unlabeled oligonucleotide was 
added to the reaction mixture  before  the labeled DNA.  A 
polyclonal rabbit antiserum to p50  subunits of NF-KB  (26) 
was kindly provided by Dr. A. Israel, Pasteur Institute, 
Paris. A  mouse  mAb to NF-Y (27) was kindly provided by 
Dr. R. Mantovani, Institut de Chimie Biologique, 
Strasbourg. Nuclear extracts  were preincubated with 1.0 p1 
of antiserum or mAb for 15 min at 20°C  before addition of 
labeled oligonucleotide probes. Thereafter, labeled probes 
were added and the incubation continued  for  a  further 30 
min.  Gels  were dried and exposed overnight at -80°C  with 
intensifying screens. 
Results 
Transcription factor TCFl (a),  NF-Y, NF-KB, and CREB 
activities in fetal thymus ontogeny 
Using EMSA, we have determined  the binding activities of 
the transcription  factors TCFl(a), NF-Y, NF-KB, and 
CREB from  day 14 of fetal development until birth (day 
20). NF-Y, a highly conserved transcription  factor  which 
recognizes CCAAT motifs in a variety of genes  (28) was 
used as a reference. The specificity of transcription factor 
binding  activities was confirmed by addition of excess  un- 
labeled homologous or mutated oligonucleotides as com- 
petitors (Fig. 1).  A  specific antiserum to the pS0 subunit of 
NF-KB (26) completely inhibited the  formation of the lower 
band (b2) and partially inhibited the upper band (bl), in- 
ducing  a supershift of band b l  (Fig. lA). Together with our 
previous UV cross-linking experiments (2), these results 
identify the  lower band (b2)  as a  homodimer of p50-p50 
NF-KB, and the upper (b2) band as a  complex  containing 
the pSO-p65 heterodimer. A  supershift  seen with mAb to 
NF-Y (but not with  control  ascites or anti-p50  antiserum) 
also demonstrated the presence of canonical  NF-Y factor 
in fetal thymus (Fig. lA). As observed previously (2), 
nuclear extracts  from day 14 fetal thymus contained 
abundant NF-KB activity, which decreased at days 16 and 
17 to rise again toward birth (Fig. 1B). The kinetics of 
TCFl(a) activity during thymus development were dif- 
ferent, with low levels at day 14 and a rise by day 16. 
CREB and NF-Y  activities remained relatively un- 
changed throughout ontogeny (Fig. 1B). 
NAC blocks thymocyte differentiation  along the ap T 
cell lineage 
To make thymocytes accessible to experimental manipu- 
lation, we employed aidliquid interface cultures of day 14 
fetal  thymus (FTOC), a  system which supports normal thy- 
mocyte differentiation (4). Cultures were  exposed to doses 
of NAC (20, 50, or 100 mM) known to inhibit NF-KB ac- 
tivation in other  systems  (15,  17), and then allowed to de- 
velop in the absence of NAC. At the indicated times, we 
analyzed cell recovery, and the expression of CD4 and CD8 
(Fig. 2). 20 mM NAC had no effect on cell recovery, 
whereas 50 mM NAC resulted in growth arrest which  was 
reversible 2  days after removal of NAC. No cell  loss  from 
FTOC was caused by 50 mM NAC in several different 
experiments.  In contrast, initial loss of cells was  seen from 
FTOC exposed to 100 mM NAC (Fig. a), but the sur- 
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FIGURE 1. A, Presence and specificity of ( A )  NF-KB, ( B )  
NF-Y, (C)  CREB, and (D )  TCF-1 (CY) transcription  factor  bind- 
ing activity in nuclear  extracts of mouse  fetal  thymocytes. B, 
Ontogeny of transcription  factor  binding  activities in nuclear 
extracts of mouse  thymocytes. A, Nuclear  extracts  were  pre- 
pared from day 15 (A, B, and C), newborn (D, lanes 78 to 
271, or  adult (D, lanes 22 to 26) thymocytes. EMSA used KB 
(A) ,  Y-box (B) ,  CRE (C) ,  or CD4=2 (D) oligonucleotides 
(compare sequences in Table I). Unlabeled homologous or 
mutated oligonucleotides (Comp.) were added at 100-fold 
(lanes 73, 75, 79, 23)  or  200-fold  excess  (all  other  lanes  with 
Comp.). Antibodies (Anti.) used were a polyclonal rabbit 
antiserum to p50 subunits of NF-KB (25)  (A, lane 4, and 6, 
lane 7 7 ) ,  preimmune  rabbit  serum (A, lane 5) ,  a mouse mAb 
to NF-Y (26)  (B, lane 9) ,  or control ascites (B,  lane 70). 
Antibodies  inhibited the formation of nuclear  protein/ 
oligonucleotide complexes and/or produced supershifts in 
viving cells were still able to proliferate and differentiate 
after removal of NAC (see below). 
Control cultures (Fig. 2B) generated abundant CD4+ 
CD8+ DP  progeny (52% of thymocytes were DP by  day 4). 
Addition of 20 mM NAC had no effect on  the phenotypic 
differentiation, but exposure to 50 mM NAC drastically 
reduced the fraction of DP thymocytes (3% DP cells at  day 
4 and 21% by day 8). An almost complete block of de- 
velopment was seen in the presence of 100 mM NAC 
(Fig. 2 B ) .  
To analyze the phenotypic properties of the DN cells in 
NAC-treated FTOC, we conducted three-color analysis 
with anti-CD25 (IL-2Ra chain), anti-CD4, and anti-CD8 
mAb. In these experiments, FTOC were treated for 24 h 
with 0, 20,  40, 60, 80, or 100 mM NAC,  and the recovery 
of CD4- and CDS-expressing cells was similar to that 
shown in Figure 2B. As shown in Figure 3, DN cells in 
freshly isolated  day 15 fetal thymus lobes contained sub- 
populations of CD25wcak and CD25hrigh' cells (R. Ceredig, 
manuscript in preparation). Forty-eight hours after removal 
of  NAC, it could  be seen that CD25+ cells were depleted 
from the 60,80, and 100 mM groups. After 72 h, DN cells 
in the 60 and 80 mM groups contained CD25wC"k and 
CD25"'gh' cells. By 120 h, CD25wcak cells had reappeared 
among DN cells from  the 100 mM group. 
Three-color FACS analysis also showed that after 12 
days in FTOC, CD3 was expressed normally by CD4-  and 
CD8-defined subsets in the control as well as in 20 mM 
NAC  (Fig.  4A). Exposure to 50 and 100 mM NAC caused 
a strong decrease in CD3 expression, particularly among 
the CD4 SP subset and CD4 CD8 DN thymocytes. By com- 
parison, CD3 expression by CD8 SP cells was only slightly 
affected, and there was essentially no effect on CD3 ex- 
pression by residual DPcells. Interestingly, changes in CD3 
expression correlated with differential effects of  NAC  on 
(YP vs y6 TCR expression. Most strikingly, NAC  markedly 
reduced the frequency of aP T cells in all thymocyte popu- 
lations. Among CD8 SP cells (but not CD4 SP  or DN cells) 
this reduction was compensated by a rise in the  proportion 
of y6 TCR positive cells. In this context, we  have  recently 
shown that during normal thymus ontogeny, yGTCRf cells 
occur within the CD8 SP as well as the DN thymocyte 
EMSA.  For (A) ,  two bands of retardation for NF-KB were 
designated bl  and b2, sb = supershift, b3 represents a non- 
specific band. For (B ) ,  NF-Y corresponds to the major, spe- 
cific band and ay to a minor CCAAT-binding protein. In all 
panels, f refers to free probe. B, Thymi were  obtained from 
embryos  at  days 14 to 18 of development  or from newborn 
(NB) mice. EMSA conducted as  described in Figure 1A. The 
day 14 fetal  thymus  contains abundant NF-KB activity  which 
decreases on days 16 and 17 relative to CREB and NF-Y. 
There is an increase in TCFl (a) activity between days 15 
and 16. 
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FIGURE 2. Kinetics of  cell recovery 
( A )  and thymocyte  differentiation ( g )  in 
FTOC cultured  for the first 48 h with 0 
(Control), 20, 50 or 100 m M  NAC. Each 
panel in Figure 3 8  represents CD8 (hori- 
ZOf f fd  axis) vs CD4 (vertical axis) ex- 
pression (logarithmic scale). The vertical 
and horizontal lines in each panel en- 
closed 99% of unstained cells in the 
lower left quadrant (not shown), and the 
percentage of cells in each quadrant is 
indicated. 
4 Control 
+ 20 mM 
* 50 mM - 100 mM 
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population (29). Taking into account cell numbers, how- 
ever, lobes from control cultures contained 5 X lo4 y6 
TCR+ cells, whereas there were 3 X lo4 from those pre- 
treated with 100 mM  NAC.  Therefore, yi3 TCR cell num- 
bers remain relatively unchanged in NAC-pretreated lobes. 
To analyze  the  functional  properties of NAC-pretreated 
R O C ,  lobes  were pretreated for 24 h with NAC, and 9 days 
later cells  were harvested and stimulated  with a mitogenic 
combination of PMA and Ionomycin. As shown in Table 11, 
cells harvested from  such  lobes  were fully capable of pro- 
liferating  and  producing IL-2 after mitogen activation. 
Effects of other antioxidant compounds on thymocyte 
differentiation 
For comparison, we used another  antioxidant  compound, 
BHA, a reagent known to inhibit the  activation of mouse 
thymocyte and peripheral T cells in response to Ag and 
mitogens (30). Recently, BHA at a concentration of 100 to 
500 pM,  was also  shown to inhibit NF-KB activity in hu- 
man T cell and monocyte lines (16). R O C  were exposed 
to BHA for 24 h, after which cultures  were transferred to 
fresh  medium.  Five  days later, thymocytes  were harvested 
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CD25 FLUORESCENCE INTENSITY 
FIGURE 3. Kinetics of  CD25 (IL-2Ra) expression by DN cells from NAC-pretreated FTOC.  The toppane/ (A)  represents CD25 
expression by DN cells from freshly isolated day 15 fetal thymus lobes. Below (panels B, C, and D) are the CD25 profiles of 
DN cells from FTOC pretreated for 24 h with the  indicated concentrations of  NAC and analyzed at ( B )  48, (C) 72, and (D )  120 
h after removal of NAC. In all instances, cells were stained with anti-CD25, anti-CD4, and anti-CD8, and the histograms 
represent the CD25 fluorescence profiles of gated D N  cells. 
and  stained for FACS analysis. At 4.0 mM  BHA, essentially 
all (92%)  thymocytes  were CD4  CD8 DN  (Fig. 5). BHA 
concentrations  below 1.0 mM did not affect thymocyte de- 
velopment. Summarizing four independent experiments, 
BHA was about 25 times  more potent than NAC;  4 mM 
BHA and 100 mM NAC had comparable  effects (Fig. 5). 
Transcription factor activities in thymocytes exposed 
to antioxidants 
Nuclear extracts  were prepared from  thymocytes cultured 
for different  times in NAC, and equal  amounts (2 pg)  of 
nuclear proteins were subjected to EMSA. As shown in 
Figure 6, control  thymocytes and cultures treated with  20 
mM NAC  contained  abundant NF-KB, CREB, and NF-Y 
activities. The only detectable effect at this  concentration 
was a slight decrease of TCFl(a) (Fig. 6A). At 50 mM 
NAC, NF-KB and especially TCFl(a) were substantially 
reduced relative to control levels, whereas  NF-Y and CREB 
activities  decreased  only slightly (Fig. 6A). TCFl(a) and 
NF-KB were  essentially  undetectable as soon as 24 h after 
exposure to 100 mM NAC. Adecrease of NF-Y activity was 
also  observed, but CREB levels remained essentially un- 
changed, declining only slightly after 2 days in 100 mM 
NAC (Fig. 6B).  Thus, reduced NF-KB and TCFl(a) levels 
appeared to correlate  with the inhibition of cwp (but not yS) 
thymocyte differentiation in FTOC (Figs. 3 and 4). Impor- 
tantly, both NF-KB and TCFl(a) returned to levels higher 
than those seen before treatment following transfer of 
FTOC to medium without NAC (Fig. 6 ,A  and B, ZunesR-5). 
Recovery of NF-KB and TCFl(a) was  more rapid in the 20 
and 50 mM than in the 100 mM  group, in which recovery 
of NF-KB preceded TCFl(a). Previous  experiments sug- 
gested that NF-KB was affected by antioxidants (15-17), 
whereas our results indicate  more  complex effects of NAC 
on transcription factor activities, in particular TCFl(a). 
Thymocyte  development and transcription factor 
activity  in submersion culture 
To test the  hypothesis that abundant NF-KB and TCFl(a) 
is associated with the development of ap  T cells, we 
employed a  culture  system in which differentiation toward 
ap vs y6 T cells can be manipulated by nonpharmaco- 
logic means. We have previously reported that submer- 
sion culture of day 14 fetal thymi yields mainly CD4 
CD8 DN and CD8  SP yS, but not cup T cells (20, 21),  a 
phenotypic  constellation  similar to that described here 
for FTOC exposed to antioxidants. Recently, Watanabe 
and Katsura (18) showed that the differentiation of aP T 
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FIGURE 4. Three-color FACS analysis 
of FTOC cultured in the presence of 
NAC. Expression of CD3 (A ) ,  ap TCR 
(B ) ,  and yS TCR ( C )  by CD4 CD8 D N  
(lower  left), CD4  CD8  DP (upper  right), 
CD4 SP (upper  left), and  CD8 SP (lower 
right). Overlays represent controls, and 
cultures exposed to 20, 50, and 100 m M  
NAC after 12 days in culture. The per- 
centages of stained cells are indicated. 
CD3 FLUORESCENCE- 
ap TCR  FLUORESCENCE- 
Table II 
Proliferation and 11-2 production by NAC-treated FTOC 
Treatment Proliferationb IL-2 Production' 
Groupa (L3H1Thymidine cpm) (U/ml) 
Control 
2 0   m M NAC 1.2 x 105 1 0  
40 mM NAC 2.0 x 105  13.2
60 mM NAC 1.5 x 105 
80 mM NAC 
11.2 
100   mM NAC 7.4 x 104  2.8 
~~ 
1.2 x 105 1 0  
1.0 x 105  2.8
of NAC and then cultured for 9 days in medium. Lobes were then harvested 
a Groups of FTOC  were treated  for 24 h  with the indicated concentrations 
and I O 5  cells stimulated with 1 ng/ml PMA  and 500 ng/rnl lonomycin. Twenty- 
four hours later, SN was harvested, and after 48 h, cellular proliferation was 
measured by [?H]thymidine incorporation. 
Values  represent the mean [3H]thymidine incorporation from duplicates 
of IO5 FTOC cells stimulated as above  and  pulsed  for 5 h. 
cIL-2 content of SN from I O 5  FTOC cells stimulated as above. Values 
determined using CTLL cells. In this assay, 50% maximum thymidine incor- 
for 5 h. 
poration with 1 U/ml r-IL-2 gave 7.5 X lo4 cpm from IO4 CTLL cells pulsed 
cells in submersion culture is  restored  under elevated O2 
concentrations. 
Submersion cultures were  set  up  in  ambient  or  60% 02, 
and thymocytes were analyzed by FACS (Fig. 7A) and 
EMSA (Fig. 7B). FTOC  generated 16.0 X lo4 thymocytes 
per lobe, whereas submersion cultures yielded 1.5 X lo4 at 
standard, and 6.5 X lo4 at high oxygen concentration. 
After 1 wk in control FTOC, day 14 thymocyte precur- 
sors had differentiated, resulting in substantial popula- 
tions of CD4 CD8 DP, CD4 SP, and CD8 SP cells. Half 
of the thymocytes (80 X lo3 per lobe) expressed detect- 
able levels of ap TCR. Fourteen percent of cells, mainly 
CD4 and CD8 SP, were aP TCR bright (Fig. 7A, panel 
A) .  In marked contrast, the majority of thymocytes in 
Control 
IOOmM 
rS TCR FLUORESCENCE - 
Control 
lOOrnM 
standard submersion culture remained CD4 CD8 DN,  and 
only 21% of all cells (3 X lo3 per lobe) expressed a/3 
TCR, 3% at  high levels (Fig. 7A, panel B ) .  Increasing the 
oxygen concentration to 60% restored the generation of 
CD4 CD8 DP and SP thymocytes and most importantly, 
the expression of ap TCR: 41% of thymocytes (26 X 
lo3 per lobe) were stained, 19% brightly (Fig. 7A, panel 
C ) .  The pattern of aP TCR expression by thymocyte sub- 
populations was normal,  with  low levels on DP and  high 
levels on SP cells (compare histogram overlays in panels 
A and C of Fig. 7A). 
EMSA with equal amounts of nuclear extract from 
FTOC  and submersion cultures at low- and  high-oxygen 
concentration  showed (Fig. 7B) that NF-KB and TCFl(a) 
was abundant  in  FTOC,  but  barely (NF-KB) or not at all 
(TCFl(a)) detectable in standard submersion culture. 
Both NF-KB and TCFl(a) activities were restored  under 
elevated oxygen concentration (Fig. 7B). NF-Y activity 
was less dependent on the culture conditions, whereas 
CREB increased in submersion culture particularly  at 
high  oxygen concentration. Taken  together with the data 
on antioxidant-treated FTOC, these results confirm the 
correlation between NF-KB and TCFl(a) activities and 
thymocyte differentiation toward  the ap T cell lineage. 
Discussion 
Nuclear NF-KB activity is abundant in the fetal thymus as 
early as day 14 (2 ,  this report),  when  most  thymocytes  are 
still devoid of TCR. Little is known  about  the interactions 
between T cell precursors and thymic stromal cells at  this 
stage, but  adhesion molecules (such as the  LFA-1/ICAM1 
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FIGURE 5. Inhibition  of thymocyte differentiation by BHA. 
FTOC were  exposed to the indicated concentrations of BHA 
and  NAC.  Cultures were transferred to fresh medium after  24 
h and  harvested  and  stained for CD4 and CD8 expression 5 
days later (see legend to Fig. 3). 
and CD2LFA-3 system, references 31-33) and lympho- 
kines (e.g., IL-1 and other factors released by thymic stro- 
mal cells, reference 34) presumably act as important me- 
diators at this stage prior to TCR expression. NF-KB is 
inducible by IL-1 in T-cell  and  pre-B cell lines in vitro (35, 
36), and it seems likely  that this and other stroma-derived 
factors regulate NF-KB activity also in the early fetal thy- 
mus. Targets for NF-KB include cytokine and receptor 
genes (IL-2,  IL-6, TNF-a, GM-CSF,  and the IL-2 receptor 
a-chain), major histocompatibility complex-related genes 
(MHC class I, and  the class I1 associated invariant chain) 
(37,38), and the murine T cell receptor /32 intron enhancer 
(39). To address the functional significance of this tran- 
A. +P ,+% lOOmMNAC B. - - + - + - 
' 0 20 50" +days 0 1  1  2 2 7 R5 "- 
- r E s  "CREB & 
I 
-NF-Y "-NF.Y 
1 2 3 4  1 2  3  4 5 6 7 8 9 1011121314 
FIGURE 6. Transcription  factor activities in nuclear ex- 
tracts from FTOC cultured in NAC. ( A )  0, 20, or 50 mM and 
( B )  100 mM NAC. In (A ) ,  three groups of 60 thymi were 
cultured for 2 days in the indicated doses of NAC. Nuclear 
proteins were  isolated from 30 lobes (lanes 1 to 3) ,  and  the 
remaining thymi were  transferred to filters on fresh medium, 
and allowed to recover for a further 5 days (R5)  (lane 4) .  In 
(81, duplicate lanes  are shown for thymi cultured for 0, 1, 2 
or 7 days (lanes 1 to 72) with ( + I ,  lanes 5, 6,/9,70or without 
(-), lanes 7 ,  2, 3, 4, 7, 8, 7 7 ,  72, NAC. As in ( A ) ,  lobes that 
had  been cultured for 2 days with NAC were transferred to 
fresh medium and allowed to recover for 5 days (R5, lanes 
73, 74). Nuclear extracts were analyzed by EMSA for the 
indicated transcription factor binding activities. 
scription factor for early thymocyte development, we at- 
tempted to inhibit nuclear NF-KB activity in fetal thymus 
organ cultures using antioxidant compounds (15, 16). Phe- 
notypic analysis showed that  both  NAC  and  BHA  inhibited 
thymocyte differentiation in a dose-dependent manner,  re- 
sulting in the accumulation of CD4 CD8 DN cells. Detailed 
analysis of DN cells from  NAC-pretreated  FTOC  showed 
that there was a dose-dependent inhibition of CD25 ex- 
pression. The data  presented in Figure 3 suggests that  NAC 
affected thymocyte differentiation at a stage before CD25 
expression by DN cells. This inhibition affected mostly  the 
ap TCR pathway  and  could not be attributed to MHC  Class 
I or Class I1 expression which was not decreased in NAC- 
treated FTOC (unpublished data). Functional analysis re- 
vealed that cells from NAC-pretreated FTOC were fully 
capable of proliferation and IL-2 production after mitogen 
stimulation. 
As expected, EMSA experiments demonstrated that an- 
tioxidants affected NF-KB. In addition, we have demon- 
strated here  that TCFl(a) activity was at least equally sen- 
sitive to antioxidants as NF-KB. Effects on NF-Y were also 
detected, whereas changes in CREB activity were relatively 
minor.  Removal of NAC  from  FTOC  resulted in the  rapid 
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FIGURE 7. Effects of oxygen concentration on A, thymo- 
cyte differentiation, and B, transcription factor activity. A, 
Day 14 fetal  thymus  lobes were cultured as  FTOC (panel A )  
or submerged in medium at ambient oxygen concentration 
(panel B )  or at 60% O2 (panel C). After 1 wk, thymocytes 
were harvested, counted, and stained with CD4-PE, CD8- 
FITC, and H-57-biotin (aP TCR) followed by streptavidin- 
cycrome (PharMingen) for three-color immunofluorescence 
analysis. The cytogram displays (top panels) show (on log 
scales) the  expression of CD4 and CD8; histogram  overlays 
below represent aP TCR staining of the populations (log 
scale). In the negative control, the biotinylated first antibody 
(aPTCR)  was omitted. 13, EMSA  was performed for the detec- 
tion of NF-KB,  NF-Y,  CREB, and TCF-1 (a) from nuclear extracts 
of fetal  thymus  lobes cultured as  FTOC or as submersion CUI- 
tures  at ambient (FTLC) or at 60% oxygen (FTLC+O,). Two 
micrograms of nuclear protein was  used in each  lane. 
recovery of NF-KB and TCFl(a) activities, and also re- 
stored thymocyte development. 
NF-KB resides in the cytoplasm in an inactive form com- 
plexed to the  inhibitor, IKB (40). Cellular activation results 
in the dissociation of IKB proteins from NF-KB with con- 
sequent translocation of active NF-KB to the nucleus (37, 
41). The precise mechanisms by which antioxidants block 
NF-KB and/or possibly TCFl(a) activation remain  unclear, 
but may be related to the scavenging of oxygen radicals 
(42), as reactive oxygen intermediates appear to participate 
in the activation of the cytoplasmic precursor of NF-KB. 
In earlier studies, we had shown  that thymus lobes sub- 
merged in liquid culture generated  primarily y6 T cells (20, 
21).  Recently,  Watanabe  and  Katsura demonstrated that el- 
evated oxygen concentrations could restore aP T cell de- 
velopment in such submerged cultures (18). This system 
provided a test for the correlation of NF-KB and TCFl(a) 
with the generation of aP T cells. Here, we show that  the 
rescue of a@ T cell development in submersion cultures by 
high oxygen indeed correlates with increased levels of 
NF-KB and TCFl(a) activity. The signaling pathway 
whereby  high concentrations of oxygen activate transcrip- 
tion factors is  unclear, but elevated levels of reactive oxy- 
gen intermediates generated in cells cultured at  high oxygen 
concentration might  play a role. The experiments confirm 
that  the  inhibition of thymocyte differentiation in NAC-  and 
BHA-treated  FTOC  and  the concomitant decrease in tran- 
scription factor activities are not simply due to toxic effects 
of the  drugs: viability of cells in submersion culture is ex- 
cellent, yet we observed a dramatic decrease in NF-KB and 
TCFl(a) which was fully reversible by increasing the O2 
concentration. 
Cells of the aP and yS T lineages differ in several im- 
portant respects including anatomical distribution, devel- 
opmental pathways, and timing of appearance (43, 44). 
Transcripts and surface expression of yS TCR begins at 
about day 13 to 14, at which time the thymus contains a 
truncated 1.0-kb TCR p transcript. The abundant NF-KB 
activity present in the fetal thymus at this time may  play a 
role in the generation of these TCR transcripts (2, 39). Ex- 
pression of a TCR transcripts, which  is controlled by sev- 
eral transcription factors including TCFl(a) (5 )  begins 2 
days later, at  day 16 (3). Presence of a TCR transcripts is 
accompanied by full-length (1.3-kb) TCRP transcripts and 
surface expression of ap TCR, along with  high  level ex- 
pression of CD4 and CD8, begins at this time (3). This 
pattern of gene expression is in good agreement with our 
finding of increased TCFl(a) activity around this time. The 
difference in ontogeny of y6 vs aPTCR expressing T-cells 
suggests that  the  two lineages may  be  independently  regu- 
lated, by for example different sets of transcription factors. 
In conclusion, we  have shown that experimental manipu- 
lations which affect NF-KB and TCFl(a) activity abrogate 
aP T cell development, but  leave the differentiation of yS 
T cells relatively unaffected.  Although only correlative at 
present, but supported by two independent experimental 
systems, our results suggest that successful development of 
aP Tcells requires conditions under  which  the transcription 
factors NF-KB and TCFl(a), and  probably others, are 
active. 
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